Åsmund Reikvam
#178,477
Most Influential Person Now
Norwegian scientist and politician
Åsmund Reikvam's AcademicInfluence.com Rankings
Åsmund Reikvammathematics Degrees
Mathematics
#8584
World Rank
#11664
Historical Rank
Group Theory
#507
World Rank
#588
Historical Rank
Algebra
#835
World Rank
#1091
Historical Rank
Measure Theory
#4994
World Rank
#5884
Historical Rank
Åsmund Reikvamcomputer-science Degrees
Computer Science
#12700
World Rank
#13598
Historical Rank
Machine Learning
#5857
World Rank
#5945
Historical Rank
Artificial Intelligence
#6316
World Rank
#6424
Historical Rank
Download Badge
Mathematics Computer Science
Åsmund Reikvam's Degrees
- Masters Mathematics Norwegian University of Science and Technology
Why Is Åsmund Reikvam Influential?
(Suggest an Edit or Addition)According to Wikipedia, Åsmund Ragnar Reikvam is a Norwegian professor in medicine and former politician. Education He graduated as dr. med. in 1976 and became a specialist in Internal medicine and Heart disease in 1981. He worked at Ullevål university hospital and Sogn og Fjordane central hospital, the latter as head physician in 1983–1984 and 1989–1992. In 1999 he was appointed professor in pharmacotherapeutics at the University of Oslo.
Åsmund Reikvam's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
- The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals (2004) (207)
- The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. (1996) (155)
- Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams (2006) (98)
- Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men (2009) (58)
- Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction Towards an understanding of factors influencing clinical practice (1998) (57)
- Diffusion chamber culturing of haematopoietic cells: methodological investigations and improvement of the technique. (1975) (47)
- Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective. (1998) (35)
- Virulence of different strains of Toxoplasma gondii and host response in mice (1976) (30)
- Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate. (2011) (25)
- Treatment with statins after acute myocardial infarction in patients ≥80 years: underuse despite general acceptance of drug therapy for secondary prevention (2006) (22)
- WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance. (2013) (22)
- The Janus face of polypharmacy - overuse versus underuse of medication (2008) (20)
- [Warfarin treatment and bleeding]. (2003) (19)
- Acute, massive poisoning with digitoxin: report of seven cases and discussion of treatment. (1981) (18)
- Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. (1998) (18)
- Use of Cardiovascular Drugs After Acute Myocardial Infarction: A Marked Shift Towards Evidence-Based Drug Therapy (2002) (18)
- Late cardiac manifestation of infection with Borrelia burgdorferi (Lyme disease). (1993) (17)
- Markedly Changed Age Distribution among Patients Hospitalized for Acute Myocardial Infarction (2002) (17)
- Changes in myocardial infarction mortality. (2011) (17)
- Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results (2014) (15)
- Choice of initial antihypertensive drugs and persistence of drug use—a 4-year follow-up of 78,453 incident users (2012) (15)
- Reduced life expectancy after an incident hospital diagnosis of acute myocardial infarction--effects of smoking in women and men. (2013) (14)
- NEW ANTICOAGULANTS AS THROMBOPROPHYLAXIS AFTER TOTAL HIP OR KNEE REPLACEMENT (2013) (14)
- Hyperthermia and rhabdomyolysis in self-poisoning with paracetamol and salicylates. Report of a case. (2009) (14)
- Hydroxyurea (HU) in experimental hematology. I. Characterization of in vitro and in vivo effects on progenitor and transit cells. (1977) (13)
- Hospital mortality from acute myocardial infarction has been modestly reduced after introduction of thrombolytics and aspirin: results from a new analytical approach. European Secondary Prevention Study Group. (1999) (12)
- [Marked increase of the number of myocardial infarctions following introduction of the new diagnostic criteria]. (2003) (12)
- Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals (2011) (11)
- [Patterns in the prescription of antihypertensive drugs in Norway, 1975-2010]. (2012) (11)
- [Acute myocardial infarctions in Norway 1991 - 2007]. (2010) (9)
- Efficacy and cost-effectiveness of new oral anticoagulants compared to warfarin for the prevention of stroke in patients with atrial fibrillation (2013) (9)
- The origin of creatine kinase BB occurring in serum during aortocoronary bypass surgery (1981) (8)
- Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals. (1997) (8)
- Blood donor selection can prevent cytomegalovirus infection after open heart surgery. (1987) (7)
- [Clinical use of COX inhibitors--a consensus]. (2006) (7)
- Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery (2011) (7)
- Primary cytomegalovirus infection following open heart surgery. (2009) (6)
- Thrombolytic treatment in diabetic patients with acute myocardial infarction: lower rates of use than in non-diabetic patients are explained by differences in presenting ECGs (2004) (5)
- Diagnostic efficiency of lactate dehydrogenase isoenzymes in serum after acute myocardial infarction. (1990) (5)
- Thrombolytic therapy for acute myocardial infarction in older patients (1996) (5)
- [Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]. (2002) (5)
- [Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]. (2002) (4)
- [Is the warfarin era over?]. (2012) (4)
- [Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]. (2002) (4)
- Macrophage proliferation and activation during Toxoplasma gondii infection in mice: relationship to lymphocyte stimulation. (1976) (4)
- [Can cardiovascular events be prevented by raising HDL cholesterol?]. (2008) (4)
- [Patient characteristics and mortality in acute myocardial infarction]. (1996) (3)
- [Use of thrombolytic agents and other drugs in acute myocardial infarction]. (1996) (3)
- Identification of patients at risk of symptomatic cytomegalovirus infection after open-heart surgery. (1985) (2)
- [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?]. (2003) (2)
- Macrophage proliferation during a lymphocyte transformation response: a study of mouse peritoneal cells stimulated antigenically in diffusion chambers. (1975) (2)
- [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events]. (2009) (2)
- [Clinical trials in Norway--completion and reporting are not satisfactory]. (2004) (2)
- The phagocytic capacity of macrophages in the S phase of the cell cycle. (1977) (2)
- [Leukocyte counts]. (1979) (2)
- [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. (2008) (2)
- [Torsades de pointes ventricular tachycardia induced by disopyramide at therapeutic serum concentration]. (1992) (1)
- Traffic accident risks associated with the prescription of medicinal drugs: a registry-based cohort study. (2008) (1)
- Pharmacoepidemiology – a discipline in rapid progress in Norway (2009) (1)
- Acute Myocardial Infarction Mortality Related to Use of Calcium Antagonists Before Admission to Hospital (1998) (1)
- [Changed digitalis dosing]. (2010) (1)
- Myocardial protection during aortocoronary bypass operations. Comparison of two different operative procedures: cold chemical cardioplegia versus intermittent cross-clamping of the aorta. (1982) (1)
- [Omega-3-fatty acids still beneficial in cardiovascular disease]. (2007) (1)
- [Do vitamins C and E protect against the development of carotid stenosis and cardiovascular disease?]. (2005) (1)
- [Calcium antagonists in treatment of hypertension]. (2009) (1)
- [Treatment with statins]. (2013) (1)
- Diagnostic accuracy of Kodak creatine kinase MB, Stratus creatine kinase MB, and lactate dehydrogenase isoenzyme 1 in serum after acute myocardial infarction. (1990) (1)
- PHAGOCYTOSIS AND MICROBICIDAL CAPACITY OF MOUSE MACROPHAGES NON-SPECIFICALLY ACTIVATED IN VITRO (2009) (1)
- [Granulocytes and macrophages: mobilization and killing of microorganisms. Normal and pathologic function]. (1977) (1)
- [Statins without prescription?]. (2005) (0)
- [How should ACE inhibitors be used in myocardial infarction?]. (2000) (0)
- [Misleading information about thiazides]. (2005) (0)
- ACTIVATED MOUSE MACROPHAGES: MORPHOLOGY, LYSOSOMAL BIOCHEMISTRY, AND MICROBICIDAL PROPERTIES OF IN VIVO AND IN VITRO ACTIVATED CELLS (2009) (0)
- [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?]. (2005) (0)
- [Guidelines--by whom and for whom?]. (2007) (0)
- [The effect of reduced cholesterol on coronary arteries]. (1998) (0)
- [Meta-analyses, magnesium and acute myocardial infarction]. (2001) (0)
- [Paracetamol poisoning--liver damage]. (1978) (0)
- [Thrombolytic therapy in acute myocardial infarction]. (1991) (0)
- External cephalic version of breech presentation (2005) (0)
- [Increasing use of antilipemic agents]. (1999) (0)
- [Nitrate therapy during and after acute myocardial infarction]. (2003) (0)
- [Thiazides (only) and hard endpoints]. (2004) (0)
- [A new myocardial infarction "epidemics"--fact or fiction?]. (2002) (0)
- [Glycoprotein IIb/IIIa antagonists as antithrombotic agents]. (2002) (0)
- [Wrong about thiazides]. (2005) (0)
- [Statins--are there differences when it comes to clinical effect?]. (2001) (0)
- Effects on soluble markers of endothelial dysfunction after 4.5 years treatment with ACE-inhibitor ramipril in patients with coronary heart disease (HOPE substudy) (2000) (0)
- [Cytomegalus infections after heart surgery]. (1982) (0)
- [Protracted digitalis poisoning]. (1987) (0)
- RAS inhibitors and size of infarct. (2011) (0)
- [The mononuclear phagocyte system]. (1976) (0)
- The origin of creatine kanase BB occurring in serum during aortocoronary bypass surgery. (1981) (0)
- [Nutrition, dietary supplementation and coronary heart disease]. (2000) (0)
- New anticoagulants as thromboprophylax is after total hip or knee replacement (2013) (0)
- [Cardiac manifestations of Borrelia burgdorferi infection (Lyme-borreliosis)]. (1993) (0)
- [From clinical trials to routine treatment. What factors are decisive for implementation of research results into clinical practice routines?]. (1994) (0)
- Reseptfritak for statiner (2005) (0)
- Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advanced Glycation End Products in Patients with Coronary Artery Disease: Results from a HOPE Substudy (2003) (0)
- Thrombolytics and aspirin in the treatment of acute myocardial infarction: towards an understanding of factors limiting their use and consequences for overall benefit (2009) (0)
- [Lung shock in connection with acute myocardial infarction. Adult respiratory distress syndrome, ARDS]. (1990) (0)
- [From clinical trials to routine treatment. General aspects of clinical trials in cardiovascular diseases]. (1994) (0)
- Selection factors fortheuse ofthrombolytic treatmentinacutemyocardial infarction: a population basedstudy ofcurrentpractice inthe United Kingdom (1995) (0)
- [Diuretics, hypertension and coronary heart disease]. (2005) (0)
- [Improved treatment of myocardial infarction--how has the hospital mortality developed?]. (1999) (0)
- [Cardiogenic shock. Therapeutic principles]. (1982) (0)
- Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results (2014) (0)
- [Fewer new drugs from drug industry]. (2007) (0)
- Choice of initial antihypertensive drugs and persistence of drug use—a 4-year follow-up of 78,453 incident users (2012) (0)
- [Statins and prevention of stroke]. (2005) (0)
- The macrophage response in mice after primary and secondary immunization with sheep red blood cells. (2009) (0)
- [Toxoplasma gondii. A review on its occurence, life cycle and transmission]. (1976) (0)
- [Rivastigmine against dementia in Parkinson disease?]. (2007) (0)
This paper list is powered by the following services:
Other Resources About Åsmund Reikvam
What Schools Are Affiliated With Åsmund Reikvam?
Åsmund Reikvam is affiliated with the following schools:
